Clinical trial
Evaluation of DEXTENZA on the Management of Pain and Inflammation in Patients With Anterior Uveitis Compared to Standard of Care Topical Corticosteroids
NCT04426734 is registered in ClinicalTrials.gov with New England Retina Associates as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluation of DEXTENZA on the Management of Pain and Inflammation in Patients With Anterior Uveitis Compared to Standard of Care Topical Corticosteroids
- Lead sponsor
- New England Retina Associates
- Phase
- Phase 4
- Overall status
- Unknown status
- Start date
- July 1, 2020
- Completion date
- March 31, 2021
- Enrollment
- 30 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
non-infectious anterior uveitis